Saturday, January 25, 2020
Breaking Medical Device Industry News
Home ALung Technologies

ALung Technologies

    ALung Announces Significant Progress in its Hemolung Clinical Trial Programs

    12/10/18: Achieves major milestones in its clinical trial programs. In the USA, nearly 30 hospitals are online for ALung’s VENT-AVOID Trial of the Hemolung Respiratory Assist System.

    ALung Submits IDE Application to FDA Seeking Approval to Conduct Pivotal Study of the Hemolung RAS

    Submission of our IDE is a significant milestone, made possible only through the hard work of our team in close collaboration with the FDA,”...

    ALung Technologies Closes $36 Million Financing

    New Funding ALung Technologies, Inc., the leading provider of low-flow extracorporeal carbon dioxide removal (ECCO2R) technologies for treating patients with acute respiratory failure, announced today...